Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Single-blind, Parallel-group Comparison Between Levofloxacin and Prulifloxacin, in Patients With Acute Exacerbation of COPD Unresponsive to Other Antibiotics and Admitted to the Internal Medicine

NCT01710488 is registered in ClinicalTrials.gov with Fadoi Foundation, Italy as lead sponsor.

NCT NCT01710488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01710488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Single-blind, Parallel-group Comparison Between Levofloxacin and Prulifloxacin, in Patients With Acute Exacerbation of COPD Unresponsive to Other Antibiotics and Admitted to the Internal Medicine
Lead sponsor
Fadoi Foundation, Italy
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2009
Completion date
November 30, 2013
Enrollment
258 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

copd exacerbation